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Abstract
The EFSA Panel on Food Additives and Flavourings was requested to evaluate 24 flavouring substances
assigned to the Flavouring Group Evaluation 73 (FGE.73), using the Procedure as outlined in the
Commission Regulation (EC) No 1565/2000. Twenty-three substances have already been considered in
FGE.73 and its four revisions ([FL-no: 02.114, 02.141, 05.098, 05.112, 08.067, 09.289, 09.488,
09.534, 09.615, 05.119, 05.123, 08.034, 08.060, 09.028, 09.536, 05.104, 09.034, 09.712, 09.305,
02.060, 02.091, 09.278, 09.302]). The remaining substance myrtenal [FL-no: 05.106] has been
cleared with respect to genotoxicity in FGE.208Rev3 and is considered in this revision 5 of FGE.73. The
substances were evaluated through a stepwise approach that integrates information on the structure–
activity relationships, intake from current uses, toxicological threshold of concern (TTC), and available
data on metabolism and toxicity. The Panel concluded that none of these 24 substances gives rise to
safety concerns at their levels of dietary intake, estimated on the basis of the ‘Maximised Survey-
derived Daily Intake’ (MSDI) approach. Besides the safety assessment of the flavouring substances,
the specifications for the materials of commerce have also been considered and found adequate for 23
substances. For [FL-no: 09.278], the stereoisomeric composition is not specified. For two substances
[FL-no: 09.034, and 09.712], the modified Theoretical Added Maximum Daily Intake (mTAMDI)
estimates are above the TTC for their structural class (I). For 17 substances evaluated through the
Procedure, no normal and maximum use levels are available. Therefore, for these 19 substances, more
detailed data on uses and use levels should be provided in order to refine their exposure assessments
and to finalise their safety evaluations.
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1. Introduction
The present revision of this Flavouring Group Evaluation (FGE) concerns the inclusion of myrtenal
[FL-no: 05.106], an a,b-unsaturated carbonyl substance that has been evaluated with respect to
genotoxicity in FGE.208Rev3 (EFSA FAF Panel, 2019). According to the Mandate and Term of
Reference of this FGE, when for a flavouring substance the concern for genotoxicity is ruled out, the
European Food Safety Authority (EFSA) proceeds to the full evaluation of this flavouring substance,
taking into account the requirements of the Commission Regulation (EC) No 1565/20001 and of
Regulation (EU) No 1334/20082. The mandates for FGE.208Rev3 are cited below.
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background of mandate from FGE.208Rev3
The use of flavourings is regulated under Regulation (EC) No 1334/20082 of the European
Parliament and Council of 16 December 2008 on flavourings and certain food ingredients with
flavouring properties for use in and on foods. On the basis of Article 9(a) of this Regulation, an
evaluation and approval are required for flavouring substances.
The Union list of flavourings and source materials was established by Commission Implementing
Regulation (EC) No 872/20123. The list contains flavouring substances for which the safety evaluation
should be completed in accordance with Commission Regulation (EC) No 1565/20001.
On July 2015, the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
(CEF) adopted an opinion on Flavouring Group Evaluation 208 Revision 1 (FGE.208Rev1):
Consideration of genotoxicity data on representatives for 10 alicyclic aldehydes with the a,b-
unsaturation in ring/side-chain and precursors from chemical subgroup 2.2 of FGE.19 (EFSA CEF Panel,
2015). This opinion was a revision of the earlier opinion on this group of substances on the basis of
additional data.
The Panel concluded that p-mentha-1,8-dien-7-al [FL-no: 05.117] is genotoxic in vivo and as that
substance was regarded as the representative of the group, there is a potential safety concern for the
other substances in this group. Following this opinion, the Commission withdrew from the Union List of
flavorings the representative substance [FL-no: 05.117]4 with an urgent procedure and also the non-
supported substances 2,6,6-trimethyl-1-cyclohexen-1-carboxaldehyde [FL-no: 05.121], myrtenyl
formate [FL-no: 09.272], myrtenyl-2-methylbutyrate [FL-no: 09.899] and myrtenyl-3-methylbutyrate
[FL-no: 09.900].5
Also, following the EFSA opinion of 2015 FGE.208Rev1, the Commission amended the conditions of
use of these five substances of this group in another Regulation,6 pending the evaluation of the
additional data.
The applicant submitted individual in vitro studies on the substances myrtenol [FL-no: 02.091],
pmentha-1,8-dien-7-ol [FL-no: 02.060], myrtenal [FL-no: 05.106], p-mentha-1,8-dien-7-yl acetate [FL-
no:09.278] and myrtenyl acetate [FL-no: 09.302]. EFSA evaluated these studies and related scientific
data in its Scientific Opinion on Flavouring Group Evaluation 208 Revision 2 (FGE.208Rev2):
Consideration of genotoxicity data on alicyclic aldehydes with a,b-unsaturation in ring/side-chain and
precursors from chemical subgroup 2.2 of FGE.19. The Panel considered as regards myrtenal [FL-no:
1 Commission Regulation (EC) No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an
evaluation programme in application of Regulation (EC) No 2232/96. OJ L 180, 19.7.2000, p. 8–16.
2 Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and certain
food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 1601/91,
Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p. 34–50.
3 Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances provided
for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex Ito Regulation (EC)
No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) No 1565/2000 and
Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p. 1–161.
4 Commission Regulation (EU) 2015/1760 of 1 October 2015 amending Annex I to Regulation (EC) No 1334/2008 of the
European Parliament and of the Council as regards removal from the Union list of the flavouring substance p-mentha-1,8-dien-
7-al. OJ L 257, 2.10.2015, p. 27–29.
5 Commission Regulation (EU) 2016/637 of 22 April 2016 amending Annex I to Regulation (EC) No 1334/2008 of the European
Parliament and of the Council as regards removal from the Union list of certain flavouring substances. OJ L 108, 23.4.2016, p.
24–27.
6 Commission Regulation (EU) 2016/1244 of 28 July 2016 amending Annex I to Regulation (EC) No 1334/2008 of the European
Parliament and of the Council as regards certain flavouring substances from a group related with an alpha, beta unsaturation
structure. OJ L 204, 29.7.2016, p. 7–10.
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05.106] assessing in particular the studies on this substance submitted by industry (a bacterial reverse
mutation assay, Mc Garry, 2016a, and two micronucleus assays in human peripheral blood
lymphocytes, Mc Garry, 2016b and Lloyd, 2017). The Panel concluded that myrtenal ‘did not induce
gene mutations in a bacterial reverse mutation assay. The first in vitro micronucleus assay provided
was equivocal and had several weaknesses, therefore a repetition of the study was requested. The
second study is considered more reliable than the first one, but the result is still not fully adequate to
rule out the concern for genotoxicity. In this second study, weak statistically significant increases of the
micronuclei frequency were observed at the lowest and highest concentrations (without statistically
significant trend) in the absence of S9-mix after long treatment, while after short treatment, there was
a statistically significant trend (without statistically significant differences between single concentrations
tested and the concurrent control). The Panel considered that the result of this second study was also
equivocal and that this was not adequately investigated by the applicant. Therefore, myrtenal cannot
be evaluated through the [EFSA] Procedure [for evaluating existing flavouring substances of the
program of Regulation 1565/2000], presentlyˊ.
In July 2018 JECFA has assessed myrtenal [FL-no: 05.106] (JECFA no. 980). The substance p-
mentha-1,8-dien-7-al [FL-no: 05.117] (JECFA no. 973) was also evaluated by JECFA at this same time. In
addition, also other substances included in this FGE were as well evaluated by JECFA at the same time.
1.1.2. Terms of Reference of Mandate from FGE.208Rev3 (M-2018-0137)
The European Commission requests the European Food Safety Authority (EFSA) to evaluate the
additional available studies on myrtenal [FL-no: 05.106] and in particular the in vivo studies. This
substance is part of the FGE.208 (FGE.19 subgroup 2.2).
Depending on the outcome, the Authority is asked to indicate if its current assessment regarding
genotoxicity of myrtenal remains or if it can proceed to the full evaluation of this flavouring substance,
taking into account the requirements of the Commission Regulation (EC) No 1565/20001 and also
those of Regulation (EU) No 1334/20082.
The Authority is also asked to consider if it is appropriate to revise the section regarding the
characterization of the hazard concerning myrtenal and also the quantification of the exposure. The
evaluation should be carried out in 6 months.
In case the EFSA Procedure of evaluation of existing flavouring substances can be applied the
Authority is asked to deliver its opinion about the application of the Procedure within 9 months from
the date of publication of the first opinion mentioned above.
1.2. Interpretation of the Terms of Reference
Myrtenal [FL-no: 05.106] was first allocated to FGE.208Rev3 (EFSA FAF Panel, 2019) for evaluation
with respect to genotoxicity. Based on the new genotoxicity data submitted, the Panel concluded that
this flavouring substance does not give rise to concern with respect to genotoxicity and can
accordingly be evaluated through the Procedure in the present revision of FGE.73 (FGE.73Rev5), in
accordance with Commission Regulation (EC) No 1565/20001.
Myrtenal belong to a group of structurally related substances which have been evaluated by the
Joint FAO/WHO Expert Committee on Food Additives (JECFA) in the past (JECFA, 2002a, 2005a,
2018a). For these substances that have been previously evaluated by JECFA, a full evaluation is not
required but EFSA should consider whether the evaluation by JECFA can be agreed to or not. If not,
EFSA should carry out a full evaluation of such substances (for further explanations see Appendix A).
1.3. History of evaluation of the substances in FGE.73
FGE.73 includes considerations on alicyclic alcohols, aldehydes, acids and related esters, which have
been evaluated by JECFA in a group of 26 flavouring substances at its 59th meeting (JECFA, 2002a,b,
2018a). Ten of the 26 JECFA-evaluated substances are a,b-unsaturated carbonyls, or precursors for
that, and they were therefore assessed for their potential genotoxicity concern in FGE.208 [FL-no:
05.117, 02.060, 09.278, 05.121, 05.106, 02.091, 09.302, 09.272], FGE.209 [FL-no: 05.104] and
FGE.207 [FL-no: 09.034]. One of the 26 JECFA evaluated substances, santalol (CAS: 115-71-9 or 77-
42-9; JECFA nr: 984), was originally included in the Register, but not included in the UL.
In FGE.73, the Panel only considered 15 of the 26 JECFA-evaluated substances and concluded that
for nine of these substances, i.e. [FL-no: 02.114, 02.141, 05.098, 05.112, 08.067, 09.289, 09.488,
09.534 and 09.615], additional data were needed (no European production volumes available,
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preventing them to be evaluated using the Procedure, and/or missing data on stereoisomerism and/or
compositional information of mixtures of the isomers).
For the remaining 6 of the 15 JECFA-evaluated substances, i.e. [FL-no: 05.119, 05.123, 08.034,
08.060, 09.028 and 09.536], the Panel agreed with the JECFA conclusion ‘no safety concern at
estimated levels of intake as flavouring substances’ based on the MSDI approach.
The first Revision of FGE.73, FGE.73Rev1, included the assessment of one additional candidate
substance, 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 05.104] (EFSA CEF Panel, 2012).
No toxicity or metabolism data were provided for the substance. Furthermore, EU production volumes
were provided for three substances, [FL-no: 02.141, 09.488 and 09.534]. After the publication of
FGE.73, the following information was received and included in revision 1: information on the
configuration for six substances [FL-no: 02.114, 02.141, 05.098, 08.067, 09.289 and 09.615] and the
composition for one substance [FL-no: 05.112].
The second Revision of FGE.73, FGE.73Rev2, included the assessment of two additional flavouring
substances, santalyl acetate [FL-no: 09.034] and santalyl phenylacetate [FL-no: 09.712] (EFSA CEF
Panel, 2013a). These two substances have been considered with respect to genotoxicity in FGE.207
(EFSA CEF Panel, 2013b) and the Panel concluded that the data available did rule out the concern for
genotoxicity and thus concluded that the substances could be evaluated through the Procedure.
Santalyl phenylacetate [FL-no: 09.712] was evaluated by JECFA at its 59th meeting (JECFA, 2002a,b)
together with other phenethyl substances. With the exception of santanyl phenylacetate [FL-no: 09.712],
these phenethyl substances were not a,b-unsaturated substances and were considered by EFSA in FGE.53
(EFSA AFC Panel, 2008) with the conclusion ‘No safety concern at estimated levels of intake as flavouring
substances’ based on the MSDI approach. As the phenethyl part of the molecules was considered not to
raise concern, the Panel concluded that santalyl phenylacetate [FL-no: 09.712] cleared from genotoxic
concern in FGE.207 (EFSA CEF Panel, 2013b), could be included in FGE.73Rev2 (EFSA CEF Panel, 2013a)
together with the other santalyl substance (santalyl acetate [FL-no: 09.034]) from FGE.207.
The third revision of FGE.73 (FGE.73Rev3) (EFSA CEF Panel, 2014a) concerned the consideration of
one JECFA-evaluated substance b-ionyl acetate [FL-no: 09.305]. b-Ionyl acetate [FL-no: 09.305] was
evaluated by JECFA at its 63rd meeting together with other monocyclic and bicyclic secondary
alcohols, ketones and related esters (JECFA, 2005a,b). b-ionyl acetate [FL-no: 09.305] may be
hydrolysed to b-ionol, which is considered as a precursor for an a,b-unsaturated ketone, and was
originally allocated to and evaluated in FGE.213Rev1 (EFSA CEF Panel, 2014b) in which it was
considered not to be of concern with respect to genotoxicity. The Panel concluded that the substance
could be included in the FGE.73Rev3.
The fourth revision of FGE.73 (FGE.73Rev4) (EFSA CEF Panel, 2017b) concerned the consideration
of four JECFA-evaluated substances p-mentha-1,8-dien-7-ol [FL-no: 02.060], myrtenol [FL-no: 02.091],
p-mentha-1,8-dien-7-yl acetate [FL-no: 09.278] and myrtenyl acetate [FL-no: 09.302]. These
substances were evaluated in FGE.208Rev2 (EFSA CEF Panel, 2017a) in which they were considered to
be of no concern with respect to genotoxicity and they were subsequently evaluated through the
procedure in FGE.73Rev4.
The 23 substances that have been considered in the above-mentioned revisions of FGE.73 will not
be readdressed in the current revision, unless additional information is provided (e.g. on production
volumes, use levels or specifications).
The present revision of FGE.73 (FGE.73Rev5) concerns the consideration on myrtenal [FL-no:
05.106], which was evaluated by JECFA in its 59th and 86th meetings (JECFA, 2002a,b, 2018a). This
substance was originally evaluated in FGE.208Rev3 (EFSA FAF Panel, 2019) in which it was considered
not to be of concern with respect to genotoxicity. Therefore, myrtenal can be evaluated in the present
FGE using the Procedure.
FGE Adopted by EFSA Link
No of
substances
FGE.73 6 March 2008 http://www.efsa.europa.eu/en/efsajournal/pub/868.htm 15
FGE.73Rev1 22 March 2012 http://www.efsa.europa.eu/en/efsajournal/pub/2638.htm 16
FGE.73Rev2 25 September 2013 http://www.efsa.europa.eu/en/efsajournal/pub/3393.htm 18
FGE.73Rev3 24 September 2014 http://www.efsa.europa.eu/en/efsajournal/pub/3862.htm 19
FGE.73Rev4 19 September 2017 http://www.efsa.europa.eu/en/efsajournal/pub/5010.htm 23
FGE.73Rev5 10 December 2019 http://www.efsa.europa.eu/en/efsajournal/pub/5970.htm 24
FGE: Flavouring Group Evaluation.
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2. Data and methodologies
2.1. Data







Appendix (Table nr) and




05.106 Myrtenal Specifications, Use
levels (mTAMDI)
Appendix B (Table B.1)
Appendix C (Table C.2)
Documentation provided to
EFSA n. 3 and 1
FL-no: FLAVIS number; FLAVIS: Flavour Information System; FGE: Flavouring Group Evaluation; mTAMDI: modified Theoretical
Added Maximum Daily Intake.
In addition, the following documentation was used:
• EU poundage data for myrtenal (MSDI) (JECFA, 2002a,b,).
• Genotoxicity data evaluated in FGE.208Rev2 (EFSA CEF Panel, 2017a) and FGE.208Rev3 (EFSA
FAF Panel, 2019).
• Data evaluated in FGE.73 and its following revisions (EFSA CEF Panel, 2012, 2013a, 2014a,
2017b).
• JECFA specifications for myrtenal [FL-no. 05.106] (JECFA, 2018b).
• 59th and 86th JECFA reports (JECFA, 2002a and JECFA, 2018).
2.2. Methodologies
This opinion was elaborated following the principles described in the EFSA Guidance on
transparency with regard to scientific aspects of risk assessment (EFSA Scientific Committee, 2009)
and following the relevant existing Guidelines from the EFSA Scientific Committee. The assessment
strategy applied for the evaluation programme of flavouring substances, as laid down in Commission
Regulation (EC) No 1565/2000, is based on the Opinion on a Programme for the Evaluation of
Flavouring substances of the Scientific Committee on Food (SCF, 1999).
2.2.1. Procedure for the safety evaluation of flavouring substances
The approach for safety evaluation of chemically defined flavouring substances as referred to in
Commission Regulation (EC) No 1565/2000, named the ‘Procedure’, is described in Appendix A.
2.2.2. Approach used for the calculation of exposure
The approach used for calculation of the intake of the flavouring substances is described in




The JECFA specifications are available for all 24 flavouring substances [FL-no: 02.114, 02.141,
05.098, 05.112, 08.067, 09.289, 09.488, 09.534, 09.615, 05.119, 05.123, 08.034, 08.060, 09.028,
09.536, 05.104, 09.034, 09.712, 09.305, 02.060, 02.091, 09.278, 09.302 and 05.106] considered in
the present opinion FGE.73Rev5 (JECFA, 2002b, 2005b, 2018b).
EFSA considerations
The newly included flavouring substance myrtenal [FL-no: 05.106] (see Table 1) has two chiral
centres. According to information provided by EFFA (Documentation provided to EFSA n. 3), the
substance is a racemate.
The Panel considered that the available specifications for myrtenal are adequate.
The Panel noted that for flavouring substance p-mentha-1,8-dien-7-yl acetate [FL-no: 09.278], the
stereoisomeric composition is not specified (see ‘EFSA comments’ column in Table B.1 – Appendix B).
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Therefore, the Panel requests information on the defined composition of the stereoisomeric mixture for
this substance.
The most recent specifications data for all 24 substances in FGE.73Rev5 are summarised in
Table B.1 – Appendix B. Table 1 below reports the newly added flavouring substance, myrtenal,
considered in FGE.73Rev5.
3.2. Estimation of intake
JECFA status
For the 24 flavouring substances considered in the present opinion FGE.73Rev5 and evaluated
through the JECFA Procedure [FL-no: 02.114, 02.141, 05.098, 05.112, 08.067, 09.289, 09.488, 09.534,
09.615, 05.119, 05.123, 08.034, 08.060, 09.028, 09.536, 05.104, 09.034, 09.712, 09.305, 02.060,
02.091, 09.278, 09.302 and 05.106], annual production volumes are available for the EU (JECFA,
2002a, 2005a, 2018a) (see Appendix C, Table C.4).
EFSA considerations
Updated EU production figure for candidate flavouring substance [FL-no: 05.106] has been
submitted by industry (Documentation provided to EFSA n. 1). From this information, an MSDI value
of 2.2 lg/person per day can be calculated for myrtenal.
For 7 out of the 24 flavouring substances in FGE.73Rev5, i.e. [FL-no: 02.060, 02.091, 05.106,
09.034, 09.278, 09.302 and 09.712], normal and maximum use levels have been submitted by
industry (Documentation provided to EFSA n. 1 and EFSA CEF Panel, 2017b) and mTAMDI values can
be calculated. The mTAMDI estimated value for the candidate substance [FL-no: 05.106] is 1,700 lg/
person per day. For two substances [FL-no: 09.034, and 09.712], the mTAMDI estimates are above the
threshold of concern for their structural class (I) and more detailed exposure data are needed to
finalise their evaluation.
No normal and maximum use levels have been provided for 17 substances ([FL-no: 02.114, 02.141,
05.098, 05.104, 05.112, 05.119, 05.123, 08.034, 08.060, 08.067, 09.289, 09.028, 09.305, 09.488,
09.534, 09.536 and 09.615]) previously considered in FGE.73Rev4.
The MSDI figures and mTAMDI intake estimates for the 24 flavouring substances in FGE.73Rev5
are shown in Appendix C – Table C.4.
3.3. Biological and toxicological data
3.3.1. ADME data
Myrtenal [FL-no: 05.106] was evaluated by JECFA, at its 59th meeting (JECFA, 2002a), within a
group of 26 substances that included alicyclic primary alcohols, aldehydes, acids and related esters.
According to JECFA, bicyclic compounds, such as myrtenal, could be oxidised to yield the
corresponding carboxylic acid. The acid metabolite would be conjugated with glucuronic acid and
excreted mainly in the urine. In a minor pathway, the aldehyde can be reduced to the alcohol and
excreted as the glucuronic acid conjugate. The endocyclic double-bond could be reduced by the action
of gut microbiota. Therefore, JECFA concluded that myrtenal can be anticipated to be metabolised to
innocuous products and can be evaluated along the A-side of the Procedure (see Appendix A.1).
FGE.12Rev5 contains flavouring substances with a monocyclic, bicyclic or tricyclic terpenoid moiety,
all with a primary oxygenated function, which are structurally related to the substances under
Table 1: Flavouring substance under evaluation in FGE.73Rev5
[FL-no] UL chemical name Structural formula Structural class*
05.106 Myrtenal Class I
FL-no: FLAVIS number; FLAVIS: Flavour Information System; FGE: Flavouring Group Evaluation.
*: Determined with OECD Toolbox (version 4.3.1 available at https://www.oecd.org/chemicalsafety/risk-assessment/oecd-qsar-
toolbox.htm).
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consideration in the present FGE. In FGE.12Rev5 (EFSA CEF Panel, 2014c) there is an extensive
description of the possible metabolic routes which would be expected for monocyclic and bicyclic
terpenoid aldehydes and alcohols. Particularly for the candidate substance myrtenal [FL-no: 05.106],
experimental data are available. Quoting from FGE.12Rev5: ‘Six male rabbits received an oral dose of
2,000 mg of 2 ((-)-myrtenal) per animal. In the urine of these animals myrtenol, dihydromyrtenol,
myrtenic acid and perillic acid could be detected. Myrtenol and dihydromyrtenol comprised together
99% of the neutral metabolite fraction (5% of the dose). Myrtenic acid represented 76% of the acid
metabolites detected in the urine, but the amount of perillic acid was not specified. The total acidic
fraction of urinary metabolites comprised 24% of the dose. These results indicate that myrtenal can be
metabolised to the corresponding carboxylic acid (myrtenic acid). The presence of perillic acid indicates
some cleavage of the strained bicyclic ring. To a lesser extent, the aldehyde can either be reduced to
myrtenol, which may be conjugated with glucuronic acid and excreted or it may undergo
hydrogenation of the double bond to yield dihydromyrtenol (myrtanol), see Figure 1 which is one of
the candidate substances [FL-no: 02.186], shown to be the major neutral metabolite and excreted
unchanged with the urine (Ishida et al., 1989). Urine was collected during 3 days post dosing. Only a
fairly low part of the administered dose was recovered. Other metabolites were not mentioned’ (EFSA
CEF Panel, 2014c).
In summary, in FGE.12Rev5 it is concluded that in mammals, monocyclic or bicyclic terpenoid
primary alcohols and aldehydes are generally oxidised to the corresponding carboxylic acid, conjugated
with glucuronic acid and then they are excreted as urinary metabolites. In a minor extent, another
possible pathway is the aldehyde reduction to the corresponding alcohol and excreted as the
glucuronide (Ishida et al., 1989; Haag and Gould, 1994). If an endocyclic double bond is present,
reduction of this double bond may also occur. Further, the cyclohexene derivatives, which may be
derived from myrtenal, may also undergo allylic hydroxylation of the ring and then possible oxidation
to keto groups or conjugation with glucuronic acid. These polar metabolites would be excreted in the
urine.
EFSA considerations
Based on the information provided by JECFA (2002a) and reported in FGE.12Rev5 (EFSA CEF Panel,
2014c), the Panel considers that neither the chemical structure of the candidate substance myrtenal
nor its available metabolic data suggest that reactive metabolites could be generated. Therefore,
myrtenal would be expected to be absorbed and metabolised to innocuous products, which are
excreted. Hence, the Panel agrees with JECFA that myrtenal [FL-no: 05.106] can be evaluated along
the A-side of the Procedure (see Appendix A.1).
Figure 1: Metabolism of myrtenal in rabbits
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3.3.2. Genotoxicity data
This revision involves the inclusion of one flavouring substance, myrtenal [FL-no: 05.106] for which
in FGE.19 a concern for genotoxicity had been identified based on the presence of a structural alert
(i.e. a,b-unsaturated carbonyl substance or precursor for that), precluding its evaluation through the
Procedure (see also Appendix A.1). Therefore, this substance was evaluated in FGE.208Rev3 where its
genotoxic potential has been assessed and ruled out (EFSA FAF Panel, 2019). Consequently, the safety
evaluation through the Procedure can be performed for myrtenal [FL-no: 05.106].
3.3.3. Toxicological data
No subacute, subchronic/chronic toxicity and carcinogenicity studies are available on myrtenal [FL-
no: 05.106] or on structurally related supporting substances.
3.4. Application of the Procedure
Application of the Procedure to myrtenal [FL-no: 05.106] from JECFA flavouring group of alicyclic
primary alcohols, aldehydes, acids and related esters (JECFA, 2002a, 2018a).
In the 59th and 86th JECFA reports, the candidate substance myrtenal [FL-no: 05.106] was
allocated to structural class I using the decision tree approach presented by Cramer et al. (1978).
In 2002, JECFA concluded that myrtenal [FL-no: 05.106] can be anticipated to be metabolised to
innocuous products (step 2) and its intake (MSDI) is below the threshold of concern for the structural
class I (i.e. 1,800 lg/person per day) (step A3). Therefore, JECFA evaluated myrtenal [FL-no: 05.106]
as to be of no safety concern at the estimated levels of intake as flavouring substances based on the
MSDI approach.
In 2018, JECFA re-evaluated myrtenal [FL-no: 05.106] in its 86th meeting since additional
genotoxicity data became available. This new assessment was performed by applying the updated
procedure scheme for the safety evaluation of flavouring agents, endorsed by JECFA at the 82nd
meeting (JECFA, 2016 and see also Appendix A.2).
In line with the previous evaluation, JECFA confirmed that this flavouring substance would not pose
a safety concern at current estimated dietary exposures.
The JECFA safety evaluations of the flavouring substances are summarised in Table D.1 –
Appendix D.
EFSA considerations
The FAF Panel agrees with JECFA with respect to the assignment of the candidate flavouring
substance [FL-no: 05.106] to Cramer class I. The Panel agrees with the way of the application of the
Procedure that has been performed for myrtenal [FL-no: 05.106] at the 59th JECFA meeting (JECFA,
2002a).
The MSDI exposure estimate for myrtenal [FL-no: 05.106] is below the threshold of concern for
structural class I (i.e. 1,800 lg/person per day) (see Table C.4 – Appendix C). Therefore the FAF
Panel concludes, at step A3 of the Procedure scheme, that myrtenal does not raise a safety concern
when used as flavouring substance at the current levels of use, based on the MSDI approach.
In addition, the Panel noted that the revised JECFA Procedure scheme (JECFA, 2016) was applied
to myrtenal at its 86th meeting (JECFA, 2018a). This new approach is in line with the modified
procedure for evaluation of substances based on the TTC approach, which has been adopted by EFSA
Scientific Committee (EFSA Scientific Committee, 2019). However, taking into consideration the
requirements set out in Commission Regulation (EC) No 1565/2000, the Panel followed the strategy as
specified in the Opinion on a Programme for the Evaluation of Flavouring substances of the Scientific
Committee on Food (SCF, 1999) (for details see Appendix A.1).
The stepwise evaluation of myrtenal [FL-no: 05.106] is summarised in Table D.1 - Appendix D.
4. Discussion
This revision 5 of FGE.73 comprises in total 24 flavouring substances, 23 of which have already
been considered in FGE. 73 and its revisions. The remaining flavouring substance myrtenal [FL-no:
05.106] has been included in this revision, following an extensive evaluation in FGE.208Rev3 of its
genotoxic potential due to the presence of a structural alert for genotoxicity (i.e. a,b-unsaturated
carbonyl or precursors for that).
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Based on consideration of structural class, metabolism data and the absence of genotoxic potential
in vivo, and the MSDI exposure estimates, the FAF Panel concludes at step A3 of the Procedure that
myrtenal, considered in this revision of FGE.73 (FGE.73Rev5), does not raise a safety concern.
For 7 out of the 24 flavouring substances in FGE.73Rev5, including the candidate substance
myrtenal (i.e. [FL-no: 02.060, 02.091, 05.106, 09.034, 09.278, 09.302 and 09.712]), normal and
maximum use levels have been submitted by industry and mTAMDI values can be calculated. The
mTAMDI estimated value for myrtenal [FL-no: 05.106] is 1,700 lg/person per day. For this substance
and for four other substances [FL-no: 02.060, 02.091, 09.278 and 09.302], the mTAMDIs are below
the TTC for their structural class I. For two substances [FL-no: 09.034 and 09.712], the mTAMDI
estimates are above the threshold of concern for their structural class (I) and more detailed exposure
information is needed to finalise their evaluation. For the previously (in FGE.73Rev4) considered 17
substances [FL-no: 02.114, 02.141, 05.104, 05.098, 05.112, 05.119, 05.123, 08.034, 08.060, 08.067,
09.028, 09.289, 09.305, 09.488, 09.534, 09.536 and 09.615], no normal or maximum use levels have
been provided. For these 17 substances, normal and maximum use levels are needed to calculate the
mTAMDI estimates in order to identify those flavouring substances that need more detailed exposure
assessment and to finalise the evaluation accordingly. To determine whether the conclusions for the 24
JECFA-evaluated substances can be applied to the materials of commerce, it is necessary to consider
the available specifications. Adequate specifications, including complete purity criteria and identity, are
available for 23 out of the 24 flavouring substances in this FGE. For substance [FL-no: 09.278], the
stereoisomeric composition is not specified.
5. Conclusions
For 24 flavouring substances in FGE.73Rev5, including the newly included substance myrtenal [FL-
no: 05.106], the Panel agrees with JECFA conclusions ‘No safety concern at estimated levels of intake
as flavouring substances’ based on the MSDI approach. Besides the safety assessment of the
flavouring substances, the specifications for the materials of commerce have also been considered and
found adequate for 23 substances. For the remaining substance [FL-no: 09.278], the Panel has
reservations as there is incomplete information on the chemical identity (composition of the
stereoisomeric composition is lacking). For 19 substances [FL-no: 02.114, 02.141, 05.098, 05.104,
05.112, 05.119, 05.123, 08.034, 08.060, 08.067, 09.028, 09.289, 09.034, 09.305, 09.488, 09.534,
09.536, 09.615, 09.712], more detailed data on uses and use levels should be provided in order to
finalise their safety evaluations.
6. Recommendations
The Panel recommends the European Commission to consider:
• to request normal and maximum use levels for [FL-no: 02.114, 02.141, 05.098, 05.104,
05.112, 05.119, 05.123, 08.034, 08.060, 08.067, 09.289, 09.028, 09.305, 09.488, 09.534,
09.536, 09.615].
• to request more detailed data on uses and use levels for substances [FL-no: 09.034 and 09.712],
as their mTAMDI exposure estimates are above the threshold of concern for their structural class
I. When these data are received, the assessment for these flavouring substances should be
updated accordingly and expanded if necessary (i.e. request of additional toxicity data).
• to request data on the stereoisomeric composition of p-Mentha-1,8-dien-7-yl acetate [FL-
no:09.278] (see Table B.1 of Appendix B).
• to change the chemical names of [FL-no: 09.289] to reflect the stereochemical configuration
and to change the CAS number for [FL-no: 09.302] (see Table B.1 of Appendix B).
Documentation as provided to EFSA
1) EFFA (European Flavour Association), 2016. EFFA Letters to Commission for clarification of
use levels and updated tonnage data for five substances in FGE.208Rev2.
2) EFFA (European Flavour Association), 2002. Letter from EFFA to Dr. Joern Gry, Danish
Veterinary and Food Administration. Dated 31 October 2002. Re.: Second group of
questions. FLAVIS/8.26.
3) EFFA (European Flavour Association), 2019. EFFA submission of additional information on
isomeric composition of myrtenal [FL-no : 05.106].
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4) Lloyd M, 2017. Myrtenal: in vitro human lymphocyte micronucleus assay. Covance Laboratories
Ltd., England. Study no. 8351223. 24 January 2017. Unpublished study report submitted by EFFA
to EFSA.
5) Mc Garry S, 2016a. Myrtenal: bacterial reverse mutation assay. Covance Laboratories Ltd.,
England. Study no. 8332788. 17 February 2016. Unpublished study report submitted by EFFA to
EFSA.
6) Mc Garry S, 2016b. Myrtenal: in vitro human lymphocyte micronucleus assay. Covance
Laboratories Ltd., England. Study no. 8332792. 10 February 2016. Unpublished study report
submitted by EFFA to EFSA.
References
Cramer GM, Ford RA and Hall RL, 1978. Estimation of toxic hazard - a decision tree approach. Food and Cosmetics
Toxicology, 16, 255–276.
EFSA AFC Panel (EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food),
2008. Flavouring Group Evaluation 53 (FGE.53) Consideration of phenethyl alcohol, aldehyde, acid and related
acetals and esters evaluated by JECFA (59th meeting) structurally related to phenethyl alcohol, aldehyde,
esters and related phenylacetic acid esters evaluated by EFSA in FGE.14 (2005) and one phenoxyethyl ester
evaluated in FGE.23 (2006). EFSA Journal 2008:6(5);710, 39 pp. https://doi.org/10.2903/j.efsa.2008.710
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2012.
Scientific Opinion on Flavouring Group Evaluation 73, Revision 1 (FGE.73Rev1): consideration of alicyclic
primary alcohols, aldehydes, acids and related esters evaluated by JECFA (59th meeting) structurally related to
primary saturated or unsaturated alicyclic alcohol, aldehyde, and esters evaluated by EFSA in FGE.12Rev2
(2011). EFSA Journal 2012;10(3):2638, 26 pp. https://doi.org/doi:10.2903/j.efsa.2012.2638
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2013a.
Scientific Opinion on Flavouring Group Evaluation 73, Revision 2 (FGE.73Rev2): consideration of alicyclic
primary alcohols, aldehydes, acids and related esters evaluated by JECFA (59th meeting) structurally related to
primary saturated or unsaturated alicyclic alcohols, aldehydes, acids and esters evaluated by EFSA in
FGE.12Rev3 (2012). EFSA Journal 2013;11(10):3393, 30 pp. https://doi.org/10.2903/j.efsa.2013.3393
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2013b.
Scientific Opinion on Flavouring Group Evaluation 207 (FGE.207): consideration of genotoxic potential for one
branched-chain aliphatic acyclic a,b-unsaturated 2-alkylated aldehyde with additional double-bonds, from
subgroup 1.1.2 of FGE.19 and four alicyclic aldehydes with the a,b-unsaturation in a side-chain, from subgroup
2.1 of FGE.19, which are considered to be covered by the one substance of subgroup 1.1.2, by EFSA. EFSA
Journal 2013;11(5):3228, 17 pp. https://doi.org/10.2903/j.efsa.2013.3228
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2014a.
Scientific Opinion on Flavouring Group Evaluation 73, Revision 3 (FGE.73Rev3): consideration of alicyclic
alcohols, aldehydes, acids and related esters evaluated by JECFA (59th and 63rd meeting) structurally related
to primary saturated or unsaturated alicyclic alcohols, aldehydes, acids and esters evaluated by EFSA in
FGE.12Rev4 (2013). EFSA Journal 2014;12(10):3862, 33 pp. https://doi.org/10.2903/j.efsa.2014.3862
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2014b.
Scientific Opinion on Flavouring Group Evaluation 213, Revision 1 (FGE.213Rev1) a,ß-unsaturated alicyclic
ketones and precursors from chemical subgroup 2.7 of FGE.19. EFSA Journal 2014;12(5):3661, 46 pp.
https://doi.org/10.2903/j.efsa.2014.3661
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2014c.
Scientific Opinion on Flavouring Group Evaluation 12, Revision 5 (FGE.12Rev5): primary saturated or
unsaturated alicyclic alcohol, aldehyde, acid, and esters from chemical groups 1, 7 and 8). EFSA Journal
2014;12(12):3911, 60 pp. https://doi.org/10.2903/j.efsa.2014.3911
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2015.
Scientific Opinion on Flavouring Group Evaluation 208 Revision 1 (FGE.208Rev1): consideration of genotoxicity
data on representatives for 10 alicyclic aldehydes with the a,b-unsaturation in ring/side-chain and precursors
from chemical subgroup 2.2 of FGE.19. EFSA Journal 2015;13(7):4173, 28 pp. https://doi.org/10.2903/j.efsa.
2015.4173
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2017a.
Scientific Opinion on Flavouring Group Evaluation 208 Revision 2 (FGE.208Rev2): consideration of genotoxicity
data on alicyclic aldehydes with a,b-unsaturation in ring/side-chain and precursors from chemical subgroup 2.2
of FGE.19. EFSA Journal 2017;15(5):4766, 44 pp. https://doi.org/10.2903/j.efsa.2017.4766
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2017b.
Scientific Opinion on Flavouring Group Evaluation 73, Revision 4 (FGE.73Rev4): consideration of alicyclic
alcohols, aldehydes, acids and related esters evaluated by JECFA (59th and 63rd meeting) structurally related
to primary saturated or unsaturated alicyclic alcohols, aldehydes, acids and esters evaluated by EFSA in
FGE.12Rev5.
Scientific Opinion on Flavouring Group Evaluation 73, Revision 5
www.efsa.europa.eu/efsajournal 12 EFSA Journal 2020;18(1):5970
EFSA FAF Panel (EFSA Panel on Food additives and Flavourings), 2019. Scientific Opinion on Flavouring Group
Evaluation 208 Revision 3 (FGE.208Rev3): consideration of genotoxicity data on alicyclic aldehydes with a,b-
unsaturation in ring/side-chain and precursors from chemical subgroup 2.2 of FGE.19. EFSA Journal 2019;17
(1):5569, 50 pp. https://doi.org/10.2903/j.efsa.2019.5569
EFSA Scientific Committee, 2009. Guidance of the Scientific Committee on Transparency in the Scientific Aspects of
Risk Assessments carried out by EFSA. Part 2: general Principles. EFSA Journal 2009;7(7):1051, 22 pp.
https://doi.org/10.2903/j.efsa.2009.1051
EFSA Scientific Committee, 2019. Guidance on the use of the Threshold of Toxicological Concern approach in food
safety assessment. EFSA Journal 2019;17(6):5708, 17 pp. https://doi.org/10.2903/j.efsa.2019.5708
EFSA and WHO (European Food Safety Authority and World Health Organization), 2016. Review of the Threshold
of Toxicological Concern (TTC) approach and development of new TTC decision tree. EFSA Supporting
Publications 2016;EN-1006, 50 pp. https://doi.org/10.2903/sp.efsa.2016.EN-1006
Haag JD and Gould MN, 1994. Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog
of limonene. Cancer Chemotherapy and Pharmacology, 34, 477–483.
Ishida T, Toyota M and Asakawa Y, 1989. Terpenoid biotransformation in mammals. V. Metabolism of (+)-
citronellal, () 7-hydroxycitronellal, citral, (-)-perillaldehyde, (-)-myrtenal, cuminaldehyde, thujone, and ()-
carvone in rabbits. Xenobiotica, 19, 843–855.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1995. Evaluation of certain food additives and
contaminants. Forty-fourth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. WHO
Technical Report Series, no. 859. Geneva.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1996. Toxicological evaluation of certain food
additives. The forty-fourth meeting of the Joint FAO/WHO Expert Committee on Food Additives and
contaminants.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1997. Evaluation of certain food additives and
contaminants. Forty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. Geneva, 6-15
February 1996. WHO Technical Report Series, no. 868. Geneva.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1999. Evaluation of certain food additives and
contaminants. Forty-ninth report of the Joint FAO/WHO Expert Committee on Food Additives. Rome, 17-26
June 1997. WHO Technical Report Series, no. 884. Geneva.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2002a. Evaluation of certain food additives. Fifty-
ninth report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series, no.
913. Geneva, 4–13 June 2004.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2002b. Compendium of food additive specifications.
Addendum 10. Joint FAO/WHO Expert Committee of Food Additives 59th session. Geneva, 4–13 June 2002.
FAO Food and Nutrition paper 52 Addition 10.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2005a. Evaluation of certain food additives. Sixty-third
report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series, no. 928.
Geneva, 8-17 June 2004.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2005b. Compendium of food additive specifications.
Addendum 12. Joint FAO/WHO Expert Committee of Food Additives 63rd session. Rome, 8–17 June 2004. FAO
Food and Nutrition paper 52 Add. 12.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2016. Evaluation of certain food additives. Eighty-
second report of the Joint FAO/WHO Expert Committee on Food Additives. HO Technical Report Series, no.
1000. Geneva, 7–16 June 2016.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2018a. Evaluation of certain food additives. Eighty
sixth report of the Joint FAO/WHO Expert Committee on Food Additives. Technical Report Series, no. 1014.
Summary and conclusion. Geneva, 12–21 June 2018.
JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2018b. Compendium of food additive specifications.
FAO and WHO. 2018. Joint FAO/WHO Expert Committee on Food Additives (JECFA), 86th Meeting June 2018.
FAO JECFA Monographs 22. Rome. 167 pp.
SCF (Scientific Committee on Food), 1995. First annual report on chemically defined flavouring substances. May
1995, 2nd draft prepared by the SCF Working Group on Flavouring Substances (Submitted by the SCF
Secretariat, 17 May 1995). CS/FLAV/FL/140-Rev2. Annex 6 to Document III/5611/95, European Commission,
Directorate-General III, Industry.
SCF (Scientific Committee on Food), 1999. Opinion on a programme for the evaluation of flavouring substances
(expressed on 2 December 1999). SCF/CS/FLAV/TASK/11 Final 6/12/1999. Annex I the minutes of the 119th
Plenary meeting. European Commission, Health & Consumer Protection Directorate-General.
Abbreviations
ADME absorption, Distribution, Metabolism, Elimination
BW body weight
CAS Chemical Abstract Service
Scientific Opinion on Flavouring Group Evaluation 73, Revision 5
www.efsa.europa.eu/efsajournal 13 EFSA Journal 2020;18(1):5970
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
CoE Council of Europe
EFFA European Flavour and Fragrance Association
FAO Food and Agriculture Organization of the United Nations
FAF Panel on Food Additives and Flavourings
FEMA Flavor and Extract Manufacturers Association
FGE Flavouring Group Evaluation
FLAVIS (FL) Flavour Information System (database)
ID identity
IR infrared spectroscopy
JECFA The Joint FAO/WHO Expert Committee on Food Additives
MS mass spectrometry
MSDI maximised survey-derived daily intake
mTAMDI modified Theoretical Added Maximum Daily Intake
NMR nuclear magnetic resonance
No number
NOAEL no observed adverse effect level
(Q)SAR (quantitative) structure–activity relationship
SCF Scientific Committee on Food
SPET single-portion exposure technique
TTC toxicological thresholds of concern
WHO World Health Organization
Scientific Opinion on Flavouring Group Evaluation 73, Revision 5
www.efsa.europa.eu/efsajournal 14 EFSA Journal 2020;18(1):5970
Appendix A – Procedure of the safety evaluation
A.1. EFSA Procedure for the safety evaluation of flavourings
The approach for a safety evaluation of chemically defined flavouring substances as referred to in
Commission Regulation (EC) No 1565/2000, named the ‘Procedure’, is shown in schematic form in
Figure A.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 2
December 1999 (SCF, 1999), which is derived from the evaluation Procedure developed by the Joint
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995,
1996, 1997, 1999), hereafter named the ‘JECFA Procedure’.7
The Procedure is a stepwise approach that integrates information on intake from current uses,
structure–activity relationships, metabolism and, when needed, toxicity. One of the key elements in the
Procedure is the subdivision of flavourings into three structural classes (I, II and III) for which
toxicological thresholds of concern (TTCs) (human exposure thresholds) have been specified.
Exposures below these TTCs are not considered to present a safety concern.
Class I contains flavourings that have simple chemical structures and efficient modes of
metabolism, which would suggest a low order of oral toxicity. Class II contains flavourings that have
structural features that are less innocuous but are not suggestive of toxicity. Class III comprises
flavourings that have structural features that permit no strong initial presumption of safety, or may
even suggest significant toxicity (Cramer et al., 1978). The TTCs for these structural classes of 1,800,
540 or 90 lg/person per day, respectively, are derived from a large database containing data on
subchronic and chronic animal studies (JECFA, 1996).
In step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The
further steps address the following questions:
• Can the flavourings be predicted to be metabolised to innocuous products8 (step 2)?
• Do their exposures exceed the TTC for the structural class (steps A3 and B3)?
• Are the flavourings or their metabolites endogenous9 (step A4)?
• Does a NOAEL exist on the flavourings or on structurally related substances (steps A5 and B4)?
In addition to the data provided for the flavouring substances to be evaluated (candidate
substances), toxicological background information available for compounds structurally related to the
candidate substances is considered (supporting substances), in order to assure that these data are
consistent with the results obtained after application of the Procedure. The Procedure is not to be
applied to flavourings with existing unresolved problems of toxicity. Therefore, the right is reserved to
use alternative approaches if data on specific flavourings warranted such actions.
7 The FAF Panel is aware that a Revised Procedure for the Safety Evaluation of Flavouring agents has been agreed by JECFA
(2016). Also, the EFSA Scientific Committee has adopted a modified procedure for evaluation of substances based on the TTC
approach (EFSA Scientific Committee, 2019). However, these developments have no impact on the present evaluation, which
should follow the requirements as set out in Commission Regulation (EC) No 1565/2000.
8 Innocuous products: products that are known or readily predicted to be harmless to humans at the estimated intake of the
flavouring agent (JECFA, 1997).
9 Endogenous substances: intermediary metabolites normally present in human tissues and fluids, whether free or conjugated;
hormones and other substances with biochemical or physiological regulatory functions are not included (JECFA, 1997).
Scientific Opinion on Flavouring Group Evaluation 73, Revision 5
www.efsa.europa.eu/efsajournal 15 EFSA Journal 2020;18(1):5970
For the flavouring substances considered in this Flavouring Group Evaluation (FGE), the EFSA Panel on
Food Additives and Flavourings (FAF) compares the JECFA evaluation of structurally related substances
with the result of a corresponding EFSA evaluation, focusing on specifications, intake estimations and
toxicity data, especially genotoxicity data. The considerations by EFSA will conclude whether the
flavouring substances are of no safety concern at their estimated levels of intake, whether additional data
are required or whether certain substances should not be evaluated through the EFSA Procedure.
The following issues are of special importance:
a) Intake
In its evaluation, the Panel as a default uses the ‘maximised survey-derived daily intake’ (MSDI)10
approach to estimate the per capita intakes of the flavouring substances in Europe.
In its evaluation, JECFA includes intake estimates based on the MSDI approach derived from both
European and USA production figures. The highest of the two MSDI figures is used in the evaluation
by JECFA. It is noted that in several cases, only the MSDI figures from the USA were available,
meaning that certain flavouring substances have been evaluated by JECFA only on the basis of these
figures. For substances in the Union List3 of flavouring substances for which this is the case, the
Panel will need European Union (EU) production figures in order to finalise the evaluation.
When the Panel examined the information provided by the European Flavour Industry on the use
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would
grossly underestimate the intake by regular consumers of products flavoured at the use levels reported
by the Industry, especially in those cases where the annual production values were reported to be
small. In consequence, the Panel had reservations about the data on use and use levels provided and
the intake estimates obtained by the MSDI approach. It is noted that JECFA, at its 65th meeting,
considered ‘how to improve the identification and assessment of flavouring agents, for which the MSDI
estimates may be substantially lower than the dietary exposures that would be estimated from the
anticipated average use levels in foods’ (JECFA, 2006).
Figure A.1: Procedure for the safety evaluation of chemically defined flavouring substances
10 EU MSDI: Amount added to food as flavour in (kg/year) 9 109/(0.1 9 population in Europe (= 375 9 106) 9 0.6 9 365) =
lg/capita per day.
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In the absence of more accurate information that would enable the Panel to make a more realistic
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an
estimate of the daily intakes per person using a modified Theoretical Added Maximum Daily Intake
(mTAMDI) approach based on the normal use levels reported by Industry (see Appendix C.2).
As information on use levels for the flavouring substances has not been requested by JECFA or has
not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the
mTAMDI approach for many of the substances evaluated by JECFA. The Panel will need information on
use levels in order to finalise the evaluation.
b) Threshold of 1.5 microgram/person per day (step B5) used by JECFA
JECFA uses the threshold of concern of 1.5 lg/person per day as part of the evaluation procedure:
‘The Committee noted that this value was based on a risk analysis of known carcinogens which
involved several conservative assumptions. The use of this value was supported by additional
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the
Committee, flavouring substances for which insufficient data are available for them to be evaluated
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 j.tg/person per day
would not be expected to present a safety concern. The Committee recommended that the Procedure
for the Safety Evaluation of Flavouring Agents, used at the forty-sixth meeting, should be amended to
include the last step on the right-hand side of the original procedure (‘Do the conditions of use result
in an intake greater than 1.5 j.tg per day?’)’ (JECFA, 1999).
In line with the opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does
not make use of this threshold of 1.5 j.tg/person per day.
c) Genotoxicity
As reflected in the opinion of SCF (1999), the Panel has in its evaluation focused on a possible
genotoxic potential of the flavouring substances or of structurally related substances. Generally,
substances for which the Panel has concluded that there is an indication of genotoxic potential in vitro,
will not be evaluated using the EFSA Procedure until further genotoxicity data are provided.
Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated through
the Procedure.
d) Specifications
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of
JECFA, since the Panel requests information on e.g. isomerism.
e) Structural Relationship
In the consideration of the JECFA evaluated substances, the Panel will examine the structural
relationship and metabolism features of the substances within the flavouring group and compare this
with the corresponding FGE.
A.2. Revised JECFA Procedure for the safety evaluation of flavouring
substances (JECFA, 2016)
Based on the recommendations from the joint EFSA/WHO experts workshop (EFSA and WHO,
2016) on how the existing TTC framework may be improved and how to develop a globally
harmonized decision-tree for a tiered approach on the application of the TTC in the risk assessment of
chemicals, the JECFA Committee proposed a revised Procedure for the safety evaluation of flavouring
substances in its 82nd meeting (JECFA, 2016).
In the revised JECFA Procedure scheme an initial question with respect to the genotoxicity potential
of the substance is introduced (i.e. if a concern for genotoxicity is identified the Procedure cannot be
applied). As a consequence, also step B5 of the old Procedure (‘Do the conditions of use result in an
intake greater than 1.5 lg/day?’) is removed as it was considered of little practical application.
Moreover, the Cramer class thresholds as applied would be adequately protective for a non-genotoxic
cancer end-point. Another important change is the deletion of the question, at step 2 of the old
Procedure, related to the expected metabolites (‘Can the substance be predicted to be metabolized to
innocuous products?’) and therefore to combine the A- and B- side of the old Procedure. The
evaluation is then based on the comparison of the highest predicted dietary exposure estimate (based
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on MSDI and SPET11 approach) of the flavouring substance with the corresponding TTC value for its
structural class.
The updated JECFA Procedure scheme is reported in the Figure A.2.
Figure A.2: Revised JECFA Procedure for the safety evaluation of flavouring substances
11 Single-portion exposure technique.
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Appendix B – Specifications
Table B.1: Summary table on specifications data for flavouring substances in FGE.73Rev5
Information included in the EU Union ListRegulation
No. (EU) 1334/2008 as amended
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Information included in the EU Union ListRegulation
No. (EU) 1334/2008 as amended
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Information included in the EU Union ListRegulation
No. (EU) 1334/2008 as amended
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Information included in the EU Union ListRegulation
No. (EU) 1334/2008 as amended
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Information included in the EU Union ListRegulation
No. (EU) 1334/2008 as amended



































































98% (60–65% a- and
30–35% b-form. 80-85%
Z vs 15–20% E (for the a)
and 75–80% Z vs 20–25%
E (for the b))
1.525–1.576
1.022–1.029
FL-no: FLAVIS number; FLAVIS: Flavour Information System; JECFA: The Joint FAO/WHO Expert Committee on Food Additives; FEMA: Flavor and Extract Manufacturers Association; CoE: Council of
Europe; CAS: Chemical Abstract Service; ID: identity; NMR: nuclear magnetic resonance; IR: infrared spectroscopy; SC: secondary components.
(a): JECFA (2002a, 2005a, 2018a), EFSA CEF Panel (2017b) and Documentation provided to EFSA n. 3.
(b): At least 95% unless otherwise specified.
(c): Solubility in water, if not otherwise stated.
(d): Solubility in 95% ethanol, if not otherwise stated.
(e): At 1,013.25 hPa, if not otherwise stated.
(f): At 20°C, if not otherwise stated.
(g): At 25°C, if not otherwise stated.
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Appendix C – Exposure estimates
C.1. Normal and Maximum Use Levels
Table C.1: Normal and maximum use levels (mg/kg) of JECFA evaluated flavouring substances in FGE.73Rev5 in food categories listed in Annex III of
Reg. (EC) 1565/2000 (Documentation provided to EFSA n. 1 and EFSA CEF Panel, 2013a,b)
Normal and Maximum use levels (mg/kg) available for JECFA evaluated substances in FGE.73Rev5
FL-no
Food Categories (EU Reg 1565/2000)
Normal use levels (a) (mg/kg)
Maximum use levels (mg/kg)











































































































































































































































































FL-no: FLAVIS number; FLAVIS: Flavour Information System; JECFA: The Joint FAO/WHO Expert Committee on Food Additives; FGE: Flavouring Group Evaluation.
(a): ‘Normal use’ is defined as the average of reported usages and ‘maximum use’ is defined as the 95th percentile of reported usages (Documentation provided to EFSA n. 2).
(b): Additional food category 05.3 (chewing-gum as per Annex II part D of Reg. (EC) 1333/2008) for which EFFA submitted use levels (Documentation provided to EFSA n. 1). These have been
considered in the calculation of mTAMDI.
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C.2. mTAMDI calculations
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is
based on the approach used by the SCF up to 1995 (SCF, 1995). The assumption is that a person may
consume the amount of flavourable foods and beverages listed in Table C.2. These consumption
estimates are then multiplied by the reported use levels in the different food categories and summed up.
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as
outlined in Commission Regulation (EC) No 1565/2000 and reported by the Flavour Industry in the
following way (see Table C.4):
• Beverages (SCF, 1995) correspond to food category 14.1
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16
• Exception a (SCF, 1995) corresponds to food category 5 and 11
• Exception b (SCF, 1995) corresponds to food category 15
• Exception c (SCF, 1995) corresponds to food category 14.2
• Exception d (SCF, 1995) corresponds to food category 12
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum.
Table C.2: Estimated amount of flavourable foods, beverages, and exceptions assumed to be
consumed per person per day (SCF, 1995)
Class of product category Intake estimate (g/day)
Beverages (non-alcoholic) 324.0
Foods 133.4
Exception a: Candy, confectionery 27.0
Exception b: Condiments, seasonings 20.0
Exception c: Alcoholic beverages 20.0
Exception d: Soups, savouries 20.0
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum)
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Table C.3: Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 into the seven SCF food categories used for
mTAMDI calculations (SCF, 1995)
Food categories according to Commission Regulation 1565/2000 Distribution of the seven SCF food categories
Key Food category Foods Beverages Exceptions
01.0 Dairy products, excluding products of category 02.0 Foods
02.0 Fats and oils, and fat emulsions (type water-in-oil) Foods
03.0 Edible ices, including sherbet and sorbet Foods
04.1 Processed fruit Foods
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds Foods
05.0 Confectionery Exception a
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding
bakery
Foods
07.0 Bakery wares Foods
08.0 Meat and meat products, including poultry and game Foods
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms Foods
10.0 Eggs and egg products Foods
11.0 Sweeteners, including honey Exception a
12.0 Salts, spices, soups, sauces, salads, protein products, etc. Exception d
13.0 Foodstuffs intended for particular nutritional uses Foods
14.1 Non-alcoholic (‘soft’) beverages, excl. dairy products Beverages
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts Exception c
15.0 Ready-to-eat savouries Exception b
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) – foods that could not be placed in categories
01.0–15.0
Foods
mTAMDI: modified Theoretical Added Maximum Daily Intake.
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Table C.4: Estimated intakes based on the MSDI approach and the mTAMDI approach
Estimated intakes based on the MSDI approach and the mTAMDI approach















02.060 p-Mentha-1,8-dien-7-ol 0.34 1 1,500 Class I 1,800
02.091 Myrtenol 0.1 0.03 980 Class I 1,800
02.114 2-(2,2,3-Trimethylcyclopent-3-enyl)ethan-1-ol 0.012 ND Class I 1,800
02.141 2-(6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethan-1-ol 33 0.01 Class I 1,800
05.098 p-Menth-1-en-9-al 0.12 ND Class I 1,800
05.106 Myrtenal 2.2 7 1,700 Class I 1,800
05.112 2,6,6-Trimethylcyclohex-1-en-1-acetaldehyde 0.24 2 Class I 1,800
05.119 (1R) 2,2,3-Trimethylcyclopent-3-en-1-yl acetaldehyde 5 ND Class I 1,800
05.123 (1R,2R,5S) 5-Isopropenyl-2-methylcyclopentanecarboxaldehyde 0.012 ND Class I 1,800
08.034 Cyclohexylacetic acid 0.12 0.4 Class I 1,800
08.060 Cyclohexanecarboxylic acid 0.061 4 Class I 1,800
08.067 1,2,5,6-Tetrahydrocuminic acid 0.012 ND Class I 1,800
09.028 2-Cyclohexylethyl acetate 0.97 ND Class I 1,800
09.034 Santalyl acetate 0.1 0.01 3,900 Class I 1,800
09.278 p-Mentha-1,8-dien-7-yl acetate 1.4 0.07 1,300 Class I 1,800
09.289 a-Campholene acetate 0.061 ND Class I 1,800
09.302 Myrtenyl acetate 0.91 0,04 1,200 Class I 1,800
09.305 b-Lonyl acetate 3.3 9 Class I 1,800
09.488 Ethyl cyclohexanepropionate 0.12 0.1 Class I 1,800
09.534 Ethyl cyclohexanecarboxylate 0.24 0.1 Class I 1,800
09.536 Methyl cyclohexanecarboxylate 0.073 0.01 Class I 1,800
09.615 p-Menth-1-en-9-yl acetate 0.85 ND Class I 1,800
09.712 Santalyl phenylacetate 0.029 1 3,900 Class I 1,800
05.104 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde 3.5 0.07 Class I 1,800
FL-no: FLAVIS number; FLAVIS: Flavour Information System; MSDI: maximised survey-derived daily intake; mTAMDI: modified Theoretical Added Maximum Daily Intake; TTC: toxicological
thresholds of concern.
(a): Based on EU production figures from JECFA (2002a,b, 2005a,b).
(b): Based on US production figures from JECFA (2002a,b, 2005a,b).
(c): Based on use levels submitted by industry (Documentation provided to EFSA n.1 and EFSA CEF Panel, 2013a,b).
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Appendix D – Summary of safety evaluations




EU Union List chemical name Structural formula
JECFA conclusions EFSA conclusion
Class(a)Evaluation procedure
path(b)Outcome on the named
compound based on the MSDI(c)
approach
Procedural path if different from JECFA,
Conclusion based on the MSDI(d) approach





A3: Intake below threshold
Step 4:(e) No – based on SPET: 1000
No safety concern at current levels of
intake
Class I
A3: Intake below threshold





A3: Intake below threshold
Step 4:(e) No – based on SPET: 1000
No safety concern at current levels of
intake
Class I
A3: Intake below threshold







A3: Intake below threshold
Class I
A3: Intake below threshold







A3: Intake below threshold
Class I
A3: Intake below threshold





A3: Intake below threshold
Class I
A3: Intake below threshold





A3: Intake below threshold
Step 4(e): No – based on SPET: 1000
No safety concern at current levels of
intake
Class I
A3: Intake below threshold
No safety concern at current levels of intake
Concluded in FGE.73Rev5
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FL-no
JECFA-no
EU Union List chemical name Structural formula
JECFA conclusions EFSA conclusion
Class(a)Evaluation procedure
path(b)Outcome on the named
compound based on the MSDI(c)
approach
Procedural path if different from JECFA,
Conclusion based on the MSDI(d) approach







A3: Intake below threshold
Class I
A3: Intake below threshold







A3: Intake below threshold
Class I
A3: Intake below threshold







A3: Intake below threshold
Class I
A3: Intake below threshold




Cyclohexylacetic acid Class I
A3: Intake below threshold
Class I
A3: Intake below threshold




Cyclohexanecarboxylic acid Class I
A3: Intake below threshold
Class I
A3: Intake below threshold




1,2,5,6-Tetrahydrocuminic acid Class I
A3: Intake below threshold
Class I
A3: Intake below threshold




2-Cyclohexylethyl acetate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold




Santalyl acetate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold
No safety concern at current levels of intake
Concluded in FGE.73Rev2
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FL-no
JECFA-no
EU Union List chemical name Structural formula
JECFA conclusions EFSA conclusion
Class(a)Evaluation procedure
path(b)Outcome on the named
compound based on the MSDI(c)
approach
Procedural path if different from JECFA,
Conclusion based on the MSDI(d) approach




p-Mentha-1,8-dien-7-yl acetate Class I
A3: Intake below threshold
Step 4:(e) No – based on SPET: 1000
No safety concern at current levels of
intake
Class I
A3: Intake below threshold
No safety concern at current levels of intake
Not applicable to the material of commerce as
pending further information on stereoisomerism




a-Campholene acetate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold
No safety concern at current levels of intake
Chemical name in the UL should be changed (see




Myrtenyl acetate Class I
A3: Intake below threshold
Step 4:(e) No – based on SPET: 1000
No safety concern at current levels of
intake
Class I
A3: Intake below threshold
No safety concern at current levels of intake
CAS nr in the UL should be changed (see ‘EFSA




b-Lonyl acetate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold




Ethyl cyclohexanepropionate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold




Ethyl cyclohexanecarboxylate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold
No safety concern at current levels of intake
Concluded in FGE.73Rev1
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FL-no
JECFA-no
EU Union List chemical name Structural formula
JECFA conclusions EFSA conclusion
Class(a)Evaluation procedure
path(b)Outcome on the named
compound based on the MSDI(c)
approach
Procedural path if different from JECFA,
Conclusion based on the MSDI(d) approach




Methyl cyclohexanecarboxylate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold




p-Menth-1-en-9-yl acetate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold




Santalyl phenylacetate Class I
A3: Intake below threshold
Class I
A3: Intake below threshold







B3: Intake below threshold
B4: Adequate NOAEL exists
Class I
B3: Intake below threshold
No safety concern at current levels of intake
Concluded in FGE.73Rev1
FGE: Flavouring Group Evaluation; SPET: single-portion exposure technique; MSDI: maximised survey-derived daily intake.
(a): Thresholds of concern: Class I = 1,800 lg/person per day, Class II = 540 lg/person per day, Class III = 90 lg/person per day.
(b): Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot.
(c): EU MSDI: Amount added to food as flavour in (kg/year) 9 109/(0.1 9 population in Europe (= 375 9 106) 9 0.6 9 365) = lg/capita per day.
(d): Refer to Appendix C for MSDI values considered by EFSA based on EU production figures submitted by industry (JECFA, 2002a,b, 2005a,b).
(e): Step 4 refers to the revised JECFA Procedure scheme (JECFA, 2016), for further details see also Appendix A.2.
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